Paul Tudor Jones Vera Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 37,737 shares of VERA stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,737Holding current value
$1.33 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$185 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$117 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$112 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$104 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$98.4 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $953M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...